Agilent Technologies Inc
AAgilent Technologies Inc AI Insights
Informational only. Not investment advice.Snapshot
- Goodwill of 4.5B is 70% of equity (6.4B) - acquisition-heavy model creates impairment risk if end markets weaken[Goodwill]
- Operating margin TTM 21.3% vs industry median 2.4% - 9x advantage reflects pricing power in analytical instruments[Operating Margin TTM]
- FCF TTM of 1.1B at 16% margin funds 71M dividends + buybacks with 1.5B cash buffer at 0.54 debt/equity[Free Cash Flow TTM]
Watch Triggers
- Gross Profit 1Y Growth: Falls below 0% or accelerates above 8% — Current 3.9% is tepid; deterioration signals pricing pressure, acceleration validates premium
- Asset Impairment Charge: Any material charge (currently 0) — 4.5B goodwill at risk if life sciences M&A thesis fails
- Operating Margin TTM: Drops below 18% — Would signal competitive erosion in core analytical instruments
Bull Case
Premium profitability (21% op margin, 18% net margin, 20% ROE TTM) with conservative leverage (0.54 D/E) enables sustained capital returns and M&A optionality
FCF conversion of 73% (1.1B FCF on 1.5B operating cash flow TTM) with capex only 6% of revenue supports dividend growth
Bear Case
P/B of 28.5x vs tangible book of only 1.4B - paying 40.6B market cap for 4.5B goodwill-heavy equity base
Revenue of 6.8B TTM barely above industry mean (5.9B) despite premium valuation - limited scale advantage
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage A's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Margin compression likely as 3.9% gross profit growth lags R&D intensity (6.6% of revenue)
- R&D spend 447M TTM requires revenue growth to maintain margins
- Gross profit growth 3.9% below historical norms
- Competitive pressure in life sciences instrumentation
Public Strategies Rankings
See how Agilent Technologies Inc ranks across different investment strategies.
Leverage A's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
A Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$39.8B | — | ||
$41.36B | — | ||
31 | — | ||
$6.95B | +6.7% | — | |
$4.57 | +3.2% | — | |
21.3% | -1.6% | — | |
18.8% | -1.0% | — | |
$1.15B | -16.1% | — | |
0.21 | -1.3% | — | |
Beta 5Y (Monthly) | unknown | — |
A Dividend History
2026
$0.25502025
$0.74402024
$0.95602023
$0.91102022
$1.06502021
$0.77602020
$0.54002019
$0.67202018
$0.61102017
$0.54502016
$0.47702015
$0.51502014
$0.39602013
$0.49202012
$0.4000A Stock Splits
A SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
12/22/25 | 10/31/25 | Unknown | |
08/29/25 | 07/31/25 | 10-Q | |
06/02/25 | 04/30/25 | 10-Q | |
03/03/25 | 01/31/25 | 10-Q | |
12/20/24 | 10/31/24 | 10-K | |
08/30/24 | 07/31/24 | 10-Q | |
06/03/24 | 04/30/24 | 10-Q | |
03/05/24 | 01/31/24 | 10-Q | |
12/20/23 | 10/31/23 | 10-K | |
08/31/23 | 07/31/23 | 10-Q | |
05/26/23 | 04/30/23 | 10-Q | |
03/03/23 | 01/31/23 | 10-Q | |
12/21/22 | 10/31/22 | 10-K | |
09/01/22 | 07/31/22 | 10-Q | |
05/31/22 | 04/30/22 | 10-Q | |
03/03/22 | 01/31/22 | 10-Q | |
12/17/21 | 10/31/21 | 10-K | |
09/01/21 | 07/31/21 | 10-Q | |
06/01/21 | 04/30/21 | 10-Q | |
03/02/21 | 01/31/21 | 10-Q | |
12/18/20 | 10/31/20 | 10-K | |
09/01/20 | 07/31/20 | 10-Q | |
06/01/20 | 04/30/20 | 10-Q | |
03/03/20 | 01/31/20 | 10-Q | |
12/19/19 | 10/31/19 | 10-K | |
08/30/19 | 07/31/19 | 10-Q | |
05/30/19 | 04/30/19 | 10-Q | |
03/05/19 | 01/31/19 | 10-Q | |
12/20/18 | 10/31/18 | 10-K | |
08/30/18 | 07/31/18 | 10-Q | |
05/31/18 | 04/30/18 | 10-Q | |
03/06/18 | 01/31/18 | 10-Q | |
12/21/17 | 10/31/17 | 10-K | |
09/06/17 | 07/31/17 | 10-Q | |
06/06/17 | 04/30/17 | 10-Q | |
03/08/17 | 01/31/17 | 10-Q | |
12/20/16 | 10/31/16 | 10-K | |
09/07/16 | 07/31/16 | 10-Q | |
06/07/16 | 04/30/16 | 10-Q | |
03/08/16 | 01/31/16 | 10-Q | |
12/21/15 | 10/31/15 | 10-K | |
09/02/15 | 07/31/15 | 10-Q | |
06/05/15 | 04/30/15 | 10-Q | |
03/10/15 | 01/31/15 | 10-Q | |
12/22/14 | 10/31/14 | 10-K | |
09/02/14 | 07/31/14 | 10-Q | |
06/04/14 | 04/30/14 | 10-Q | |
03/05/14 | 01/31/14 | 10-Q | |
12/19/13 | 10/31/13 | 10-K | |
09/06/13 | 07/31/13 | 10-Q | |
06/03/13 | 04/30/13 | 10-Q | |
03/06/13 | 01/31/13 | 10-Q | |
12/20/12 | 10/31/12 | 10-K | |
09/05/12 | 07/31/12 | 10-Q | |
06/04/12 | 04/30/12 | 10-Q | |
03/05/12 | 01/31/12 | 10-Q | |
12/16/11 | 10/31/11 | 10-K | |
09/07/11 | 07/31/11 | 10-Q | |
06/07/11 | 04/30/11 | 10-Q | |
03/09/11 | 01/31/11 | 10-Q | |
12/20/10 | 10/31/10 | 10-K | |
09/07/10 | 07/31/10 | 10-Q | |
06/07/10 | 04/30/10 | 10-Q | |
03/10/10 | 01/31/10 | 10-Q | |
12/21/09 | 10/31/09 | 10-K | |
09/04/09 | 07/31/09 | 10-Q | |
06/09/09 | 04/30/09 | 10-Q | |
03/12/09 | 01/28/09 | Unknown | -- |
12/19/08 | 10/30/08 | Unknown | -- |
09/05/08 | 07/31/08 | 10-Q | |
06/05/08 | 04/30/08 | 4 | |
03/07/08 | 01/29/08 | Unknown | -- |
12/21/07 | 10/30/07 | Unknown | -- |
09/07/07 | 07/31/07 | 10-Q | |
06/05/07 | 04/30/07 | 10-Q | |
03/09/07 | 01/28/07 | Unknown | -- |
12/22/06 | 10/30/06 | Unknown | -- |
09/06/06 | 07/31/06 | 10-Q | |
06/06/06 | 04/30/06 | 10-Q | |
03/09/06 | 01/28/06 | Unknown | -- |
01/17/06 | 10/30/05 | Unknown | -- |
09/07/05 | 07/31/05 | 10-Q | |
06/06/05 | 04/30/05 | 10-Q | |
03/10/05 | 01/28/05 | Unknown | -- |
12/21/04 | 10/30/04 | Unknown | -- |
09/02/04 | 07/31/04 | 10-Q | |
06/03/04 | 04/30/04 | 4 | |
03/04/04 | 01/29/04 | Unknown | -- |
12/22/03 | 10/30/03 | Unknown | -- |
09/09/03 | 07/31/03 | 10-Q | |
06/04/03 | 04/30/03 | 4 | |
03/12/03 | 01/28/03 | Unknown | -- |
12/20/02 | 10/30/02 | Unknown | -- |
09/13/02 | 07/31/02 | 10-Q | |
06/05/02 | 04/30/02 | 10-Q | |
03/06/02 | 01/28/02 | Unknown | -- |
01/22/02 | 10/30/01 | Unknown | -- |
09/14/01 | 07/31/01 | 10-Q | |
06/14/01 | 04/30/01 | 10-Q | |
03/19/01 | 01/28/01 | Unknown | -- |
01/17/01 | 10/30/00 | Unknown | -- |
09/01/00 | 07/31/00 | 10-Q | |
06/12/00 | 04/30/00 | 10-Q | |
03/15/00 | 01/29/00 | Unknown | -- |